Pharmaceutical Technology

JUNE 6, 2025

June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.

Communication 52

Communication Hospitals Packaging Compounding 52

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.

Vaccines 52

Vaccines Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 10, 2025

June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will be used to advance Mosanna’s nasal spray for obstructive sleep apnoea. Credit: Pixel-Shot/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 6, 2025

June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The authorisation in the EU signifies a step forward in eye care for paediatric patients. Credit: chaponta/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook argenx is collaborating with regional regulatory authorities to facilitate patient access to the treatment. Credit: Wirestock Creators/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 17, 2025

Abigail Beaney June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook With potential tariffs and other changes in the US market, it is important for European companies to show they have a scalable model if they want to break into the market. Give your business an edge with our leading industry insights.

Communication 59

Communication Hospitals Packaging Insurance 59

Pharmaceutical Technology

JUNE 26, 2025

June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Regulus becomes Novartis’ indirect wholly owned subsidiary. Find out more The development follows an agreement in April 2025 in which Novartis signed an agreement to acquire Regulus and its oligonucleotide therapy, farabursen. Credit: JHVEPhoto/Shutterstock.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 1, 2025

Frankie Fattorini July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The EU Pharma Package’s attempt to balance priorities risks achieving none. Data protection reduction contentious One of the major revisions of the EU Pharma Package is to decrease the period of exclusivity offered to drug developers.

Packaging 52

Packaging Chemotherapy Communication Hospitals 52

Pharmaceutical Technology

JUNE 10, 2025

June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. Credit: MargJohnsonVA/Shutterstock. “We Give your business an edge with our leading industry insights. Login Registration is disabled.

FDA 52

FDA Research Laboratories Communication Hospitals 52

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Orion will obtain access to Glykos’ ADC technologies for probable expansion into three new programmes. Credit: Premreuthai/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmacy Times

JULY 3, 2025

It's cognitive behavioral therapy packaged as a digital experience. I've even seen VR experiences, so it can be packaged in any type of digital experience. Getting this passed would mean broadening coverage within CMS, and then, hopefully, private insurers would follow suit.

Compounding Pharmacies 81

Compounding Pharmacies FDA Immunization Packaging 81

Pharmaceutical Technology

JULY 4, 2025

Robert Barrie July 4, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Only 4% of global drugs sales in 2030 will have patent protection. In May 2025, the US president signed an executive order that overhauled pharmaceutical pricing in the country. How will RFK Jr’s American dream for vaccines play out?

Chemotherapy 52

Chemotherapy Packaging Communication Hospitals 52

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 18, 2025

Abigail Beaney June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Genomics CEO Professor Sir Peter Donnelly with Justin Ash, CEO of Spire Healthcare. Image credit: Genomics. Oxford-based company Genomics is launching its Health Insights test across the UK, which will be used to predict and prevent diseases.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 27, 2025

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The alliance between the two entities will increase the production of new cancer therapies such as CAR T-cell treatment. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Packaging Hospitals Vaccines 52

Pharmaceutical Technology

JUNE 27, 2025

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Label updates have been approved for BMS’ CAR T cell therapies, Breyanzi and Abecma, to treat multiple myeloma. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Labelling 52

Labelling FDA Packaging Communication 52

Pharmaceutical Technology

JUNE 23, 2025

Robert Barrie June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bayer’s Eylea is a heavyweight of the ophthalmic drug landscape, approved for a range of eye diseases. The biosimilar specialist’s stock has been falling over the past year, though the company did post strong Q1 2025 results earlier this year.

Communication 52

Communication Hospitals Packaging Labelling 52

Pharmaceutical Technology

JUNE 16, 2025

June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Ethris’ platform technologies have shown favourable results in Phase I trials for ETH47. Credit: Cryptographer/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Vaccines 52

Vaccines Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 25, 2025

June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funding will support the development and commercialisation of RAS(ON) inhibitor to treat cancers. Credit: SmartPhotoLab/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JUNE 19, 2025

June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025. The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JULY 16, 2025

July 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Acumen and JCR have conducted feasibility studies assessing their combined technologies. Anticipated next steps involve generating preclinical candidate data packages, which will include non-human primate studies expected in early 2026.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 1, 2025

July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Piramal Pharma Solutions Lexington expansion groundbreaking. A ground-breaking ceremony was held on 25 June 2025 to mark the commencement of work on Lexington’s site expansion. Credit: Piramal Pharma Ltd/PRNewswire. Login Registration is disabled.

Communication 52

Communication Packaging Hospitals Insurance 52

Pharmaceutical Technology

JULY 7, 2025

July 7, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Ekterly is intended for treating acute attacks of hereditary angioedema. In April 2025, KalVista Pharmaceuticals granted Kaken Pharmaceutical the commercialisation rights for sebetralstat in Japan. How will RFK Jr’s American dream for vaccines play out?

FDA 122

FDA Packaging Communication Hospitals 122

Pharmaceutical Technology

JUNE 6, 2025

June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new facility in Hungary will create 100 local jobs. Credit: SCHOTT Pharma. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network. Login Registration is disabled.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 20, 2025

Robert Barrie June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The positive opinion issued by the EMA’s Committee for Medicinal Products for Human Use (CHMP) signals a strong chance that its drug will be approved. A decision is expected in August 2025. Login Registration is disabled.

Communication 59

Communication Hospitals Packaging Insurance 59

Pharmaceutical Technology

JULY 2, 2025

Robert Barrie July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Analysis by GlobalData’s Pharma Intelligence Centre forecasts Alyftrek will bring in sales of $6.1bn by 2031. How will RFK Jr’s American dream for vaccines play out? JHVEPhoto via Shutterstock. The pharma company has a market cap of $116bn.

Packaging 52

Packaging Communication Hospitals FDA 52

Pharmaceutical Technology

JULY 9, 2025

Ross Law July 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The panel discussed topics around regulation changes in oncology research. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Login Registration is disabled.

Packaging 52

Packaging Hospitals Communication FDA 52

Pharmaceutical Technology

JULY 10, 2025

July 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook PTSD is a mental health condition that can occur after experiencing or witnessing a life-threatening or traumatic event. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

FDA 52

FDA Packaging Hospitals Communication 52

Pharmaceutical Technology

JUNE 9, 2025

June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook YOLT-101 will be a new treatment possibility for familial hypercholesterolemia. Credit: aipicte/Shutterstock. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

FDA 52

FDA Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is studying the therapy in the global Phase IIb PRIZM trial. Credit: Volha_R/Shutterstock. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

FDA 52

FDA Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 19, 2025

Robert Barrie June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Both Kisunla and Leqembi are both approved by the Medicines and Healthcare products Regulatory Agency (MHRA), meaning they will still be available privately. Give your business an edge with our leading industry insights.

Communication 59

Communication Hospitals Packaging Insurance 59

Pharmaceutical Technology

JUNE 9, 2025

Alex Watt June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The delays in market access in individual EU member states have been an obstacle to the industry. Credit: New Africa via Shutterstock. times more products than the overall European average. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 25, 2025

Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook PET scans play in an integral part in patients receiving anti-amyloid therapies. Credit: Utthapon wiratepsupon via Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Labelling 52

Labelling Packaging Communication FDA 52

Pharmaceutical Technology

JUNE 24, 2025

June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition will add a suite of products designed for addiction treatment. Finalisation of the transaction hinges on approval during a general meeting scheduled for 14 July 2025, with plans set for completion the following day.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 2, 2025

July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Merck executive board chair and CEO Belén Garijo. The merger, announced in April 2025 , will positively impact Merck’s financial position by contributing to revenues immediately, and is anticipated to be accretive to its earnings per share by 2027.

Packaging 52

Packaging Communication FDA Hospitals 52

Pharmaceutical Technology

JULY 2, 2025

July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BTCs include cholangiocarcinoma and gallbladder cancer. In March 2025, Jazz Pharmaceuticals signed an agreement to acquire Chimerix for $935m. How will RFK Jr’s American dream for vaccines play out? Credit: mi_viri/Shutterstock.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 8, 2025

July 8, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The collaboration will leverage Chugai’s antibody engineering technologies to create new drug candidates. How will RFK Jr’s American dream for vaccines play out? Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

Packaging 52

Packaging Immunization Hospitals Communication 52